EDITAS MEDICINE, INC. Shareholders' Equity
EDITAS MEDICINE, INC. (EDIT) had Shareholders' Equity of $105.28 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $105.28M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.41M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $27.29M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $13.45M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $105.28M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $4.41M 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $27.29M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $13.45M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $19.19M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $62.42M 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $134.27M 10-Q · filed 2026-08-05 | |
| 2024-09-30 | $175.63M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $232.01M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $294.40M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $349.10M 10-K · filed 2026-03-09 | |
| 2023-09-30 | $360.46M 10-Q · filed 2024-11-04 | |
| 2023-06-30 | $399.92M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | $317.47M 10-Q · filed 2024-11-04 | |
| 2022-12-31 | $360.68M 10-K · filed 2025-03-05 | |
| 2022-09-30 | $414.75M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $465.41M 10-Q · filed 2023-11-03 | |
| 2022-03-31 | $512.76M 10-Q · filed 2023-11-03 | |
| 2021-12-31 | $553.64M 10-K · filed 2025-03-05 | |
| 2021-09-30 | $586.79M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $613.36M 10-Q · filed 2022-11-02 | |
| 2021-03-31 | $638.00M 10-Q · filed 2022-11-02 | |
| 2020-12-31 | $393.59M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $441.15M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $426.77M 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $234.57M 10-Q · filed 2021-11-09 | |
| 2019-12-31 | $262.44M 10-K · filed 2023-02-22 | |
| 2019-09-30 | $209.99M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $193.06M 10-Q · filed 2020-11-06 | |
| 2019-03-31 | $217.16M 10-Q · filed 2020-11-06 | |
| 2018-12-31 | $236.16M 10-K · filed 2022-02-24 | |
| 2018-09-30 | $224.45M 10-Q · filed 2019-11-12 | $224.45M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $231.33M 10-Q · filed 2019-11-12 | $231.33M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $247.51M 10-Q · filed 2019-11-12 | $247.51M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $208.08M 10-K · filed 2021-02-26 | |
| 2017-09-30 | $177.79M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $185.00M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $206.46M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $134.61M 10-K · filed 2020-02-26 | |
| 2016-09-30 | $170.18M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $187.33M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $201.36M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | -$83.11M 10-K · filed 2019-03-01 | |
| 2014-12-31 | -$15.29M 10-K · filed 2018-03-08 | |
| 2013-12-31 | -$1.76M 10-K · filed 2017-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |